NDC 70121-2702 – Boncresa

Denosumab 60 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC70121-2702

Product details

Brand name
Boncresa
Generic name
Denosumab-mobz
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761456
Marketed since
December 23, 2025
Listing expires
December 31, 2026
Pharmacologic class
RANK Ligand Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Boncresa →

Package NDC codes (1)

Package NDCDescriptionSince
70121-2702-11 SYRINGE in 1 CARTON (70121-2702-1) / 1 mL in 1 SYRINGEDec 23, 2025